ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026
[An Improved Faster R-CNN Method for Wound Detection].
Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: By introducing an attention enhancement mechanism and improving the post-processing strategy, the Faster Region-based Convolutional Neural Network (Faster R-CNN) is enhanced. The resulting improved Faster R-CNN method for wound detection (WD-IFRCNN) increases the accuracy and stability of wound detection. Methods: ① Algorithm construction: The 50-layer residual network (ResNet-50) is used as the backbone. In the fourth residual stage (convolutional stage 4, Conv4_x) and fifth residual stage (convolutional stage 5, Conv5_x), the fuzzy mask attention module (FMAM) and convolutional block attention module (CBAM) are embedded together to enhance the model's ability to represent features in key areas and blurry regions of the wound surface. At the same time, soft non-maximum suppression (Soft-NMS) replaces the traditional non-maximum suppression strategy to reduce missed detections in overlapping target scenarios. ② Algorithm validation: The experimental dataset consists of open-source wound images and clinically collected images, totaling 740 original images. After data augmentation, the dataset expands to 5920 images and is evaluated using ten-fold cross-validation. Model performance is assessed through internal validation, external validation, hyperparameter tuning, and ablation experiments, using metrics such as precision, recall, average precision, and F1 score. Results: ① Internal validation showed that the model performs best when CBAM is embedded in both the Conv4_x and Conv5_x stages of ResNet-50. When ResNet-50-CBAM is used as the backbone, the model's detection performance surpasses that of VGG16 and ResNet-50. ② External validation showed that WD-IFRCNN achieves an precision of 92.31%, recall of 93.95%, average precision of 92.33%, and F1 score of 0.93. The average precision was 3.21%, 2.30%, 1.39%, 0.86%, 0.82%, 0.37%, and 0.63% higher than SSD, YOLOv4, YOLOv5, YOLOv8, DETR, RT-DETR, and FR-CNN-FPN, respectively. ③ Ablation experiments showed that CBAM, FMAM, and Soft-NMS each positively impact model performance, with the best results achieved when all are used together. Conclusion: WD-IFRCNN effectively enhances the model's ability to represent features in key areas and blurry regions of the wound surface, improves the accuracy and stability of wound detection, and demonstrates good adaptability to complex wound scenarios. It can provide technical support for clinical wound assessment and auxiliary diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.